DARPA and Harvard ink $16 million agreement to identify and test FDA-approved drugs for COVID-19

DARPA and Harvard ink $16 million agreement to identify and test FDA-approved drugs for COVID-19



The U.S. Defense Advanced Research Projects Agency has inked a deal with Harvard's Wyss Institute worth up to $16 million to use technology to identify and test FDA-approved drugs that could be used in the battle against COVID-19.

https://ift.tt/2YEfZs1